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1. Introduction 
Previous publications of our group [ 1,2] have 
demonstrated that 5 X lo-’ mol/kg of the alkylating 
agent 2,3,5trisethyleneiminobenzoquinone (Trenimon), 
a concentration which does not inhibit DNA synthesis 
but blocks cell multiplication, causes a drastic inhibi- 
tion of [3H]lysine incorporation into all histone frac- 
tions of Ehrlich ascites tumor cells. At the same 
Trenimon concentration, the [‘Hllysine incorporation 
into chromosomal non-histone proteins and into total 
cellular proteins is unaffected. Based on these data it 
is concluded that the drug selectively inhibits histone 
biosynthesis. Riches and Harrap [3] have observed 
similar effects with chlorambucil. Since DNA synthesis 
remains unaffected, Trenimon uncouples DNA and 
histone biosyntheses - two processes which are 
normally tightly co-ordinated. The inhibition of histone 
biosynthesis may be caused by a decrease of biologi- 
cally active histone messenger RNA. The studies 
presented here demonstrate that this is indeed the case. 
2. Materials and methods 
L[5-3H]Arginine (17 Ci/mmol), L[4,5-3H]leucine 
(35 Ci/mmol), L[4,5-3H]lysine (20 Ci/mmol) and 
[5,6-3H]uridine (35 Ci/mmol) were obtained from 
The Radiochemical Centre (Amersham, UK). All 
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unlabelled amino acids were purchased from Boehringer 
Mannheim (Mannheim, FRG). CM-Cellulose type 
CM-52 was obtained from Whatman. ATP, GTP, crea- 
tine phosphate and creatine kinase were purchased 
from Boehringer Mannheim (Mannheim, FRG). All 
other reagents were from Merck (Darmstadt, FRG). 
2,3,5-Trisethyleneiminobenzoquinone (Trenimon = 
triaziquone, WHO recommended) was kindly donated 
by Farbenfabrik Bayer (Leverkusen, FRG). 
Various groups of 30 Ehrlich ascites tumor-bearing 
male NMRI/Han mice received a single injection of 
Trenimon as indicated, 3-4 days after tumor-trans- 
plantation. Control animals received a corresponding 
volume of 0.14 M NaCl. After 1 h all animals were 
injected with 0.1 mCi uridine; 30 min later all mice 
were killed and the cells were harvested as described 
previously [4] . The cells were lysed in 5 mM MgClz 
with 20 strokes in a tightly fitting Dounce homo- 
genizer. An isotonic solution was obtained by adding 
a corresponding volume of 1.5 M sucrose-O. 15 M 
KCl. The lysate was centrifuged at 20 000 X g for 
20 mm and the polysomes were pelleted from the 
resulting supernatant by centrifugation through 36% 
sucrose at 105 000 X g for 120 min. Polysomal RNA 
from Ehrlich ascites tumor cells was prepared and 
fractionated by the method described by Breindl and 
Gallwitz [ 51. 
Gel electrophoresis of fractionated polysomal RNA 
was performed on 3.5% polyacrylamide gels. The 
reticulocytes were prepared from rabbits according to 
the method described by Evans and Lingrel [6] ; cells 
were lysed according to [5]. The composition of the 
cell-free system is described by Lockard and Lingrel 
[7]. For fractionation of the products formed in vitro, 
the method of Breindl and Gallwitz [5] was used with 
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the exception that the polyacrylamide gel electro- 
phoresis was performed at pH 3.2 in 15% gels containing 
6.25 M urea. For radioactivity measurements liced 
gels were solubilized in NCS and after addition of 10 ml 
scintillator [8] counted in a liquid scintillation spec- 
trophotometer. 
3. Results 
A fraction of polysomal RNA enriched in 9 S RNA 
was prepared as described under Materials and methods. 
The effect of Trenimon on the radioactive labelling of 
this RNA is shown in lig.1. In the control, the poly- 
acrylamide gel electrophoretic pattern has a radio- 
activity peak in the region 3.0-4.5 cm from the start. 
This peak corresponds to the 9-l 1 S region and should 
contain, among other RNA species, histone messenger 
RNA [5]. Histone messenger RNA from HeLa cells 
(kindly donated by Dr D. Gallwith) migrates into this 
region. After treatment of Ehrlich ascites tumor cells 
with Trenimon less radioactivity is observed in this 
area. The radioactivity in the region corresponding to 
the 4-5 S and 18 S RNA does not represent the total 
intracellular 4-5 S and 18 S RNA as a variable loss of 
these RNA species occurs during the isolation of the 
9SRNA. 
Figure 2 shows that this 9 s RNA-enriched prepara- 
tion stimulates the incorporation of amino acids into 
acid-soluble proteins. These proteins are retained by 
carboxymethylcellulose and, after elution with 0.25 N 
HCl-6 M urea, are recovered in fractions No. 24-30 
of the eluate (peak B of fig.2). The proteins of peak A 
1 3 5 7 1 3 5 7 1 3 5 cm 
Fig.1. Polyacrylamide gel electrophoresis of fractionated 
(9 S rich) polysomal RNA. Electrophoresis was performed 
with 0.45 A,,, RNA/gel. 
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Fig.2. Separation of the translation products of 9 S rich 
polysomal RNA by carboxymethylcellulose chromatography. 
3.2A 160 of each RNA preparation were added to a cell-free 
system from rabbit reticulocytes. The labelled proteins were 
extracted by 0.5 N HCl and separated on CM-cellulose. Peak A 
represents globin. (o - l ) without exogenous RNA, (x - x) 
control, (A-A) 10e6 moles/kg Trenimon, (o - o) 5 X lo-’ 
moles/kg Trenimon. 
and of the fractions No. 21-23 are mainly coded by 
endogenous messenger RNA of the reticulocyte lysate. 
As can be seen, the amount of protein obtained in 
peak B is reduced if RNA from Trenimon treated cells 
is employed. Gel electrophoresis of the translation 
products of peak B fig.2 exhibits a typical histone 
pattern (fig.3). Only small amounts of Hl histones 
seem to be formed in the reticulocyte system; this is 
in accordance with observations of other authors [5]. 
In agreement with the authors cited above [5] we 
assume that the radioactivity in the region 5.0-5.5 cm 
from the start corresponds to incomplete histones. 
Table 1 shows that in the in vitro system, the synthesis 
of histones is reduced by approximately 60%, if mRNA 
from Trenimon treated cells is used. 
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Fig.3. Characterization of the translation products of peak B 
(fig.2) by polyacrylamide gel electrophoresis. (A) 13H]lysine 
labelled histones prepared from Ehrlich ascites tumor cells. 
(B) proteinsof peak B (control). (C) Proteins of peak B 
(10e6 moles/kg Trenimon). (D) Proteins of peak B (5 X lo-’ 
moles/kg Trenimon). Without exogenous RNA there is no 
radioactivity in the region 3-7 cm from the start. 
4. Discussion 
Previous findings from our group indicate that low, 
but chemotherapeutically active, doses of Trenimon 
produce modifications of the nucleoprotein including 
an inhibition of the template activity for DNA- 
dependent RNA synthesis [4,9]. Preceding studies 
have demonstrated [ 1,2] that Trenimon selectively 
inhibits the incorporation of [3H]lysine into all his- 
tone fractions of Ehrlich ascites tumor cells. The studies 
presented here indicate that the inhibitory effect of the 
drug on histone biosynthesis can be explained by a 
decrease of the polysomal histone messenger RNA con- 
tent. Ninety minutes after administration of the 
alkylating agent the amount of functionally active 
histone messenger RNA is reduced to approximately 
40% of the control. Considering the lifetime of histone 
messenger RNA in mouse L cells of 11 h [lo] , it seems 
unlikely that the observed effect is due to an inhibi- 
tion of the transcription of histones genes. A drug 
induced enhancement of the degradation of histone 
messenger RNA seems to be a more adequate explana- 
tion of the phenomenon. This assumption is in accor- 
dance with the effect of hydroxyurea on histone mes- 
senger RNA in synchronised HeLa cells [ 1 l] . As the 
[jH]lysine incorporation into other proteins is not 
Table 1 
Effect,of trisethyleneiminobenzoquinone (Treniinon) on 
histone biosynthesis in vitro. For experimental details 
see Materials and methods. The translation products 
corresponding to peak B of fig.2 were subjected to poly- 
acrylamide gel electrophoresis. The gels were scanned 
for radioactivity. Peaks corresponding to histones were 
evaluated planimetrically. 
Trenimon 
(moles/kg) 
Histone biosynthesis in vitro 
(% of control) 
5 x lo-’ 44 
10-6 41 
6 x lo-’ 29 
inhibited [l] it must be concluded that the histone 
messenger RNA is preferentially affected by Trenimon. 
Is there any explanation for this specifity? It has 
been suggested that poly(A) protects messenger RNA 
against degradation by exonucleases [ 121. Histone 
messenger RNA lacks poly(A) and is characterized by 
a shorter lifetime than other messenger RNA molecules 
[ 10,l l] . We suggest hat the drug activates a non- 
specific RNAase. Due to the absence of the poly(A) 
protection, histone messenger RNA will suffer most 
from this activated nuclease, whereas the cleavage of 
the poly(A)’ messengers hould occur at a much slower 
rate. However, the lifetime of histone messenger RNA 
in the cells used in our studies is unknown. It cannot 
be excluded, therefore, that the decrease in the amount 
of histone messenger RNA is caused by an inhibition 
of the formation of histone messenger RNA. A specific 
impairment of the histone genes by the alkylating agent 
is difficult to envisage. But, as a consequence of the 
relatively short lifetime of histone messenger RNA, a 
general inhibition of transcription will affect the bio- 
synthesis of histones much earlier than the formation 
of proteins translated from more stable messengers. 
The concentrations used in these studies of the 
alkylating agent Trenimon inhibit the biosynthesis of 
the histones but do not affect DNA replication [2]. 
Thus, the drug produces an uncoupling of DNA and 
histone biosyntheses. This effect offers an explanation 
for the arrest of the tumor cells in the Gz-phase which 
is observed after treatment with low doses of Trenimon 
[2] and other alkylating agents [ 131. 
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